Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vitasora HealthASX:VHL +7.69% 3-1 Month Momentum % is -7.14% as of Aug. 18, 2026. The stock has 6 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Vitasora Health ranks better than 86.33% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-18), Vitasora Health's 3-1 Month Momentum % is -7.14%.
The industry rank for Vitasora Health's 3-1 Month Momentum % or its related term are showing as below:
ASX:VHL's 3-1 Month Momentum % is ranked better than 86.33% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: -2.08
vs ASX:VHL: -7.14
Vitasora Health (ASX:VHL) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Vitasora Health 3-1 Month Momentum % Related Terms
ASX:VHL vs VEEV, BTSG, HQY: 3-1 Month Momentum % Comparison
For the Health Information Services subindustry, Vitasora Health's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitasora Health 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Vitasora Health's 3-1 Month Momentum % falls into.
Vitasora Health (ASX:VHL) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitasora Health (ASX:VHL) has a 3-1 Month Momentum % of -7.14% as of Aug. 18, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vitasora Health and its competitors. According to the industry distribution chart, Vitasora Health ranks #92 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 13.7%.
Is Vitasora Health's 3-1 Month Momentum % too high?
Vitasora Health's current 3-1 Month Momentum % is -7.14%. Based on the distribution chart, Vitasora Health ranks #92 out of 673 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Vitasora Health's 3-1 Month Momentum % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #92 out of 673 companies for 3-1 Month Momentum %. This places Vitasora Health in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vitasora Health and its competitors. Vitasora Health's current 3-1 Month Momentum % is -7.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current 3-1 Month Momentum % of -7.14%. The current 3-1 Month Momentum % is -7.14%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current 3-1 Month Momentum % is -7.14% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VHL has been successfully added to your 
